Tricuspid atresia laboratory findings: Difference between revisions
m (Vishnu Vardhan Serla moved page Tricuspid atresia laboratory tests to Tricuspid atresia laboratory findings) |
|||
| (8 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Template: Tricuspid atresia}} | |||
__NOTOC__ | __NOTOC__ | ||
{{Template:Tricuspid atresia}} | {{Template:Tricuspid atresia}} | ||
{{CMG}} '''Associate Editor-In-Chief:'''{{Sara.Zand}} | |||
==Overview== | |||
In [[cyanotic]] older patients laboratory findings may include:[[Polycythemia]] due to secondary [[erythrocytosis]], elevated [[prothrombin time]] and [[partial thromboplastin time]], decreased levels of factors 5,7,8,9: qualitative and quantitative, [[platelet disorder]], increased [[fibrinolysis]] and paradoxical [[thrombotic]] tendency, [[proteinuria]], [[hyperuricemia]], [[renal failure]], [[uric acid]] [[nephrolithiasis]] | |||
==[[Tricuspid atresia]] laboratory findings== | |||
In [[cyanotic]] older patients laboratory finding may include:<ref name="pmid28393783">{{cite journal |vauthors=Bhardwaj V, Malhotra P, Hasija S, Chowdury UK, Pangasa N |title=Coagulopathies in cyanotic cardiac patients: An analysis with three point - of - care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer) |journal=Ann Card Anaesth |volume=20 |issue=2 |pages=212–218 |date=2017 |pmid=28393783 |pmc=5408528 |doi=10.4103/aca.ACA_4_17 |url=}}</ref> | |||
* [[Polycythemia]] due to secondary [[erythrocytosis]] | |||
* Elevated [[prothrombin time]] and [[partial thromboplastin time]] | |||
* Decreased levels of factors 5,7,8,9: qualitative and quantitative | |||
* [[Platelet disorder]] | |||
* Increased [[fibrinolysis]] and paradoxical [[thrombotic]] tendency | |||
* [[Proteinuria]] | |||
* [[Hyperuricemia]] | |||
* [[Renal failure]] | |||
* [[Uric acid]] [[nephrolithiasis]] | |||
==References== | ==References== | ||
Latest revision as of 16:57, 8 November 2020
|
Tricuspid atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Tricuspid atresia laboratory findings On the Web |
|
American Roentgen Ray Society Images of Tricuspid atresia laboratory findings |
|
Risk calculators and risk factors for Tricuspid atresia laboratory findings |
|
Tricuspid atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Tricuspid atresia laboratory findings On the Web |
|
American Roentgen Ray Society Images of Tricuspid atresia laboratory findings |
|
Risk calculators and risk factors for Tricuspid atresia laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief:Sara Zand, M.D.[2]
Overview
In cyanotic older patients laboratory findings may include:Polycythemia due to secondary erythrocytosis, elevated prothrombin time and partial thromboplastin time, decreased levels of factors 5,7,8,9: qualitative and quantitative, platelet disorder, increased fibrinolysis and paradoxical thrombotic tendency, proteinuria, hyperuricemia, renal failure, uric acid nephrolithiasis
Tricuspid atresia laboratory findings
In cyanotic older patients laboratory finding may include:[1]
- Polycythemia due to secondary erythrocytosis
- Elevated prothrombin time and partial thromboplastin time
- Decreased levels of factors 5,7,8,9: qualitative and quantitative
- Platelet disorder
- Increased fibrinolysis and paradoxical thrombotic tendency
- Proteinuria
- Hyperuricemia
- Renal failure
- Uric acid nephrolithiasis
References
- ↑ Bhardwaj V, Malhotra P, Hasija S, Chowdury UK, Pangasa N (2017). "Coagulopathies in cyanotic cardiac patients: An analysis with three point - of - care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer)". Ann Card Anaesth. 20 (2): 212–218. doi:10.4103/aca.ACA_4_17. PMC 5408528. PMID 28393783.